PRMT6 acts as an oncogene in LUAD by epigenetically repressing p18 expression, which impedes the G1/S phase transition and facilitates tumor cell proliferation in both in vitro and in vivo models [79]. The gene discussed is PRMT6; the disease is neoplasm.